A Phase II Trial of Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 13 Mar 2018 Planned primary completion date changed from 1 May 2017 to 1 May 2022.
- 24 Jan 2017 Status changed from not yet recruiting to recruiting.
- 28 Jul 2016 New trial record